Nine groups of New Zealand White male rabbits (n = 6/group) were used in this study. Group 1 and 2 animals were treated with 0.9% normal saline,

but fed either with a normal or cholesterol-added diet (negative control), respectively. Group 3 – 5 and 6 – 8 were given orally with the different volume (0.5, 1.0 and 2.5 ml/kg/day) of VCOA or VCOB followed by the cholesterol-added diet. Group 9 were treated with 5 mg/kg Atorvastatin and fed a cholesterol-added diet. All groups SHP099 were treated for 8 weeks and blood samples were taken from the marginal ear vein prior to treatment (day 0), weeks 4 and 8 for the analysis of plasma. The rabbits fed with different volume of VCOs showed significant (P < 0.05) reduction www.selleckchem.com/products/Vorinostat-saha.html in plasma cholesterol and LDL cholesterol levels compared to the control group in weeks 4 and 8. The triglycerides level increased significantly (P < 0.05) on week 4 before reduced on week 8, to a level that is still significant when compared to week

0. The HDL level also increased significantly (P < 0.05) on weeks 4 and 8 after treatment. Fatty acid analysis revealed the presence of all important fatty acids. Both VCOs showed insignificant effect on all parameters measured when compared together. In conclusion, the MARDI-produced VCOs appeared to possess great potentials as antihypercholesterolemic agent that required further in-depth study.”
“Background: Malaria is hyper-endemic and a major public health problem

in Sierra Leone. To provide malaria treatment closer to the community, Medecins Sans Frontieres (MSF) launched a community-based project where Community Malaria Volunteers (CMVs) tested and treated febrile children and pregnant women for malaria using rapid diagnostic tests (RDTs). RDT-negative patients and severely ill patients were referred to health facilities. This study sought to determine the referral rate and compliance of patients referred by the CMVs.

Methods: In MSF’s operational area in Bo and Pujehun districts, Sierra Leone, a retrospective analysis of referral records was carried out for a period of three months. All referral records from CMVs and referral health structures were reviewed, compared Entinostat ic50 and matched for personal data. The eligible study population included febrile children between three and 59 months and pregnant women in their second or third trimester with fever who were noted as having received a referral advice in the CMV recording form.

Results: The study results showed a total referral rate of almost 15%. During the study period 36 out of 2,459 (1.5%) referred patients completed their referral. There was a significant difference in referral compliance between patients with fever but a negative RDT and patients with signs of severe malaria. Less than 1% (21/2,442) of the RDT-negative patients with fever completed their referral compared to 88.2% (15/17) of the patients with severe malaria (RR = 0.010 95% CI 0.006 – 0.015).